Diagnostic performance of bone scintigraphy and 11C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer

被引:15
|
作者
Garcia, J. R. [1 ]
Moreno, C. [1 ]
Valls, E. [1 ]
Cozar, P. [1 ]
Bassa, P. [1 ]
Soler, M. [1 ]
Alvarez-Moro, F. J. [1 ]
Moragas, M. [1 ]
Riera, E. [1 ]
机构
[1] Unidad PET CETIR ERESA, Barcelona, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 2015年 / 34卷 / 03期
关键词
Bone scintigraphy; C-11-Choline PET/CT; Bone metastases; Biochemical recurrence; Prostate cancer; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; F-18-FLUORIDE PET; F-18-FDG PET/CT; DISEASE; SPECT; ONCOLOGY; RELAPSE; CT;
D O I
10.1016/j.remn.2014.08.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To compare bone scan (BS) with C-11-Choline PET/CT for the detection of bone metastases in patients with biochemical recurrence of prostate cancer (PC). Material and Methods: A total of 169 patients with biochemical recurrence of PC(PSA:2.4-58 ng/ml) who were referred for both exams (0-15 days-in-between) were included. Lesion-detection-rate per patients and lesions were analyzed for both BS and C-11-Choline PET/CT. Metastasis diagnosis was reached by: biopsy, CT/F-18-Fluoride PET/MRI confirmation, or evidence of progression in subsequent imaging procedures. Results: A total of 91 lesions were found to be active in BS and/or C-11-choline PET/CT (40 patients), with 78 of which were metastatic. BS detected 38 blastic, 2 lytic and 10 non-CT-evident lesions. C-11-Choline PET/CT detected 41 blastic, 4 lytic and 29 non-CT-evident lesions. BS and C-11-Choline PET/CT sensitivities were 65.4% and 96.1%; specificities ere 38.5 and 92.3% (chi(2) 8.27, p < 0.04). Both imaging techniques were negative in 118 patients. Tracer avid lesions were found in 51 patients: with 30/51 being BS and C-11-Choline PET/CT concordant; in 21/51 patients had discordant lesions (kappa 0.712, p = 0.00). Lesions were absolutely discordant in 10/19 patients,: 5 FN BS, 2 FP BS (degenerative changes: dysplasia), 1 FN C-11-Choline PET/CT (blastic), 1 FP C-11-Choline PET/CT (degenerative), 1 out of field-of-view lesion with C-11-Choline PET/CT (tibia alone). C-11-Choline PET/CT showed extraosseous involvement in 26/51 patients with bone metastases: 9 local recurrences, 5 infra-diaphragmatic-lymph-nodes, 2 supra-diaphragmatic, 5 local and infra-diaphragmatic, 4 infra- and supra-diaphragmatic, 1 supra-diaphragmatic and lung metastases. Conclusion: C-11-Choline PET/CT yielded better sensitivity and specificity than BS for the detection of bone involvement in patients with biochemical recurrence of PC and allowed extraosseous restaging, with an impact in the clinical management of these patients. (C) 2014 Elsevier Espana, S.L.U. and SEMNIM. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [41] Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer
    Arvola, Samuli
    Seppanen, Marko
    Malaspina, Simona
    Matzke, Sorjo
    Raiko, Juho
    Timonen, Kirsi L.
    Ettala, Otto
    Jambor, Ivan
    Anttinen, Mikael
    Kuisma, Anna
    Loyttyniemi, Eliisa
    Bostrom, Peter J.
    Sohlberg, Antti
    Noponen, Tommi
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (05) : 510 - 517
  • [42] Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
    Ghedini, Pietro
    Bossert, I.
    Zanoni, L.
    Ceci, F.
    Graziani, T.
    Castellucci, P.
    Ambrosini, V.
    Massari, F.
    Nobili, E.
    Melotti, B.
    Musto, A.
    Zoboli, S.
    Antunovic, L.
    Kirienko, M.
    Chiti, A.
    Mosconi, C.
    Ardizzoni, A.
    Golfieri, R.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (05) : 751 - 758
  • [43] Incidental Diagnosis of Diffuse Large B-Cell Lymphoma by 11C-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
    Garcia Garzon, J. R.
    Bassa, Pere
    Moragas, Merce
    Soler, Marina
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (08) : 742 - 743
  • [44] Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
    von Eyben, Finn E.
    Kairemo, Kalevi
    ANNALS OF NUCLEAR MEDICINE, 2016, 30 (06) : 385 - 392
  • [45] Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases
    Zhang, Yiqiu
    Li, Beilei
    Wu, Bing
    Yu, Haojun
    Song, Junyi
    Xiu, Yan
    Shi, Hongcheng
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (08) : 549 - 558
  • [46] Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
    Pietro Ghedini
    I. Bossert
    L. Zanoni
    F. Ceci
    T. Graziani
    P. Castellucci
    V. Ambrosini
    F. Massari
    E. Nobili
    B. Melotti
    A. Musto
    S. Zoboli
    L. Antunovic
    M. Kirienko
    A. Chiti
    C. Mosconi
    A. Ardizzoni
    R. Golfieri
    S. Fanti
    C. Nanni
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 751 - 758
  • [47] 11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer
    Ceci, Francesco
    Castellucci, Paolo
    Graziani, Tiziano
    Schiavina, Riccardo
    Chondrogiannis, Sotirios
    Bonfiglioli, Rachele
    Costa, Stefano
    Virgolini, Irene J.
    Rubello, Domenico
    Fanti, Stefano
    Colletti, Patrick M.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (05) : E265 - E270
  • [48] PSMA-11 PET/CT for Detection of Recurrent Prostate Cancer in Patients With Negative Choline PET/CT
    Pinot, Fanny
    Le Pennec, Romain
    Abgral, Ronan
    Blanc-Beguin, Frederique
    Hennebicq, Simon
    Schick, Ulrike
    Valeri, Antoine
    Fournier, Georges
    Le Roux, Pierre-Yves
    Salaun, Pierre-Yves
    Robin, Philippe
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 248 - 257
  • [49] Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
    Johannes Schwenck
    Hansjoerg Rempp
    Gerald Reischl
    Stephan Kruck
    Arnulf Stenzl
    Konstantin Nikolaou
    Christina Pfannenberg
    Christian la Fougère
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 92 - 101
  • [50] Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases
    Kara, P. Ozcan
    Kara, T.
    Gedik, G. Kara
    Sari, O.
    Sahin, O.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (02): : 94 - 96